Genetic predisposition syndromes: when should they be considered in the work-up of MDS?
about
Bone marrow pathologic abnormalities in familial platelet disorder with propensity for myeloid malignancy and germline RUNX1 mutation.Clinical utility of gene panel-based testing for hereditary myelodysplastic syndrome/acute leukemia predisposition syndromes.Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC).A germline ERBB3 variant is a candidate for predisposition to erythroid MDS/erythroleukemia.Preleukemia: one name, many meanings.Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation.
P2860
Genetic predisposition syndromes: when should they be considered in the work-up of MDS?
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Genetic predisposition syndromes: when should they be considered in the work-up of MDS?
@ast
Genetic predisposition syndromes: when should they be considered in the work-up of MDS?
@en
type
label
Genetic predisposition syndromes: when should they be considered in the work-up of MDS?
@ast
Genetic predisposition syndromes: when should they be considered in the work-up of MDS?
@en
prefLabel
Genetic predisposition syndromes: when should they be considered in the work-up of MDS?
@ast
Genetic predisposition syndromes: when should they be considered in the work-up of MDS?
@en
P2860
P1476
Genetic predisposition syndromes: when should they be considered in the work-up of MDS?
@en
P2093
Daria V Babushok
Monica Bessler
P2860
P356
10.1016/J.BEHA.2014.11.004
P577
2014-11-12T00:00:00Z